Results

Total Results: 1,363 records

Showing results for "years".

  1. www.cahps.ahrq.gov/data/visualizations/ed-visit-suicidal-ideation.html
    February 01, 2021 - presents statistics on ED visits related to suicidal ideation or suicide attempt among individuals age 5 years … visits per 100,000 population related to suicidal ideation or suicide attempt for individuals ages 5-24 years … , 25-64 years, and 65+ years.
  2. www.cahps.ahrq.gov/cahps/about-cahps/25timeline.html
    April 01, 2024 - Assessment of Healthcare Providers and Systems (CAHPS®) About CAHPS Celebrating 25 Years … Patient Experience CAHPS Announcements Contact CAHPS Celebrating 25 Years … of the CAHPS Program For 25 years, AHRQ has developed evidence-based surveys to support healthcare … homes Care for specific health conditions Health plans and related programs Access CAHPS ® : 25 Years … reviewed April 2024 Page originally created October 2020 Internet Citation: Celebrating 25 Years
  3. Materials VI-A (pdf file)

    www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-164-materials-vi-a.pdf
    March 09, 2017 - 7 years 252,360 182,914 72.5% 67,567 36.9% 64,464 35.2% 52,907 28.9% 1,300 0.7% 541 8 years 242,915 … 0.4% 380 12 years 218,152 157,969 72.4% 61,099 38.7% 42,208 26.7% 18,861 11.9% 360 0.2% 276 13 yearsyears 184,371 116,226 63.0% 19,356 16.7% 1,013 0.9% 255 0.2% 10 0.0% 89 18 years 173,561 53,720 31.0% … 212 5 years 60,879 70,281 34.6% 103 50,472 55,741 27.5% 21 1,343 2,090 1.0% 11 157 6 years 57,026 … 13 years 24,633 30,372 20.1% 40 8,566 10,590 7.0% 11 231 338 0.2% 1 23 14 years 10,760 15,848 11.1%
  4. www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-202-tech-specs.pdf
    October 11, 2018 - Parents' Evaluation of Developmental Status (PEDS), birth - 8 years Non-recommended tools are those … " using "Ages and Stages Questionnaire (ASQ), 2 months - 5 years User Defined QDM Value Set (1.1.1.1) … " using "Bayley Infant Neuro-developmental Screen (BINS), 3 months - 2 years User Defined QDM Value Set … " using "Child Development Inventory (CDI), 18 months - 6 years User Defined QDM Value Set (1.1.1.1)" … " using "Child Development Review-Parent Questionnaire (CDR-PQ), 18 months - 5 years User Defined QDM
  5. www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-212-appendix-2.pdf
    January 17, 2024 - CORTICOSTEROIDS (ICS) ICS NDC Code Brand Name Generic Product Name Route Drug ID Device FDA-Age (Years … and older N N N Y ICS NDC Code Brand Name Generic Product Name Route Drug ID Device FDA-Age (Years … Budesonide budesonide 0.5 mg/2 mL inhalation suspension inhalation d04276 Nebulizer 12 mon – 8 years … Budesonide budesonide 0.5 mg/2 mL inhalation suspension inhalation d04276 Nebulizer 12 mon – 8 years … and older N N N Y ICS NDC Code Brand Name Generic Product Name Route Drug ID Device FDA-Age (Years
  6. www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-177-section-2-technical-specs.pdf
    May 23, 2014 -  1-5 years  6-11 years  12-17 years  18-20 years  Total The total is the sum of the age … Daily Dose Criteria 13-17 years Average Daily Dose Criteria 18-20 years Asenapine Maleate >20 … Average Daily Dose Criteria 10-12 years Average Daily Dose Criteria 13-17 years Average Daily … Report three age stratifications and a total rate:  1–5 years.  6–11 years.  12–17 years. … Average Daily Dose Criteria for 10 12 years Average Daily Dose Criteria for 13 17 years Aripiprazole
  7. www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/measure_retirement/supplemental-materials/supplementaldoc2.pdf
    September 01, 2014 - 3 years: 28% (5) Enrollees age 1 year: 19, 61 Age 2 years: 23, 50 Age 3 years: 18, 35 … Chlamydia Screening (females ages 16– 20 years) Sexually active females ages 16–20 years (MAX … Adolescent Well-Care Visits: Persons Ages 12– 21 Years Enrollees ages 12–17 years (MAX b ): … –6 years: 86, 92 Ages 7–11 years: 86, 93 Ages 12–19 years: 86, 92 Enrollees ages 12–24 … months: Mixed Ages 25 months–6 years: Downward Ages 7–11 years: Mixed Ages 12–19 years
  8. www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-230-tech-specs.pdf
    July 12, 2019 - CHIPRA 230: Technical Specifications 1 The percentage of children, ages 2 through 17 years … For children ≥16 years of age, BMI score is sufficient. … Weight Classification Using BMI percentile, children 2 through 17 years of age can be classified into … Ages 2 through 17 years of age. … BMI score qualifies if child is 16 or 17 years of age.
  9. www.cahps.ahrq.gov/sites/default/files/wysiwyg/ncepcr/resources/practice-profile-template.docx
    May 14, 2021 - PATIENTS # of unique patients in practice:_____ Age distribution % Race/Ethnicity % 0-10 years … Hispanic & Latino 11-18 years American Indian/Alaska Native 19-45 years Asian 46 … -64 years Black or African American 65-79 years Native Hawaiian or other Pacific Islander … 80+ years White Insurance % Payers & Comments Commercial Medicare Medicaid
  10. www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-201-asthma-section-2-tech-specs.pdf
    March 12, 2019 - Technical Specifications This measure assesses the percentage of children, ages 1 through 17 years … record data and is calculated as a percentage as follows: Percentage of children ages 1 through 17 years … Ages Children no younger than 1 year on January 1 of the measurement year but younger than 18 years … with (acute) exacerbation 493.92 Denominator The number of children ages 1 through 17 years … indicating cystic fibrosis or bronchiectasis (Table 2) Specification • Children younger than 6 years
  11. www.cahps.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/James.pdf
    January 01, 2004 - Prologue—Volume 1—Five Years Later—Are We Any Safer? … 1 Prologue Five Years Later—Are We Any Safer? Brent C. … Five years have passed. … past 5 years have been. … Five Years Later-Are We Any Safer?
  12. www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-157-section-6b.pdf
    August 10, 2018 - Ref. 6-12 years old / 0.324d 0.322d 0.325d 0.310d 0.310d 0.309d 1-5 years old / 0.728 0.726 0.735 … Ref. 6-12 years old / 0.324d 0.322d 0.325d 0.310d 0.310d 0.309d 1-5 years old / 0.728 0.726 0.735 … Ref. 6-12 years old / 0.329d 0.327d 0.327d 0.310d 0.310d 0.309d 1-5 years old / 0.738 0.735 0.739 … Ref. 6-12 years old / 0.411d 0.411d 0.413d 0.357d 0.359d 0.359d 1-5 years old / 0.893 0.892 0.904 … Ref. 6-12 years old / 0.411d 0.411d 0.413d 0.357d 0.358d 0.359d 1-5 years old / 0.894 0.893 0.905
  13. www.cahps.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/hospital/facilscanform.doc
    November 15, 2019 - Less than 1 year ( d. 11 to 15 years ( b. 1 to 5 years ( e. 16 to 20 years ( c. 6 to 10 years … ( f. 21 years or more 2. … Less than 1 year ( d. 11 to 15 years (b. 1 to 5 years ( e. 16 to 20 years ( c. 6 to 10 years ( … f. 21 years or more 3. … Less than 1 year ( d. 11 to 15 years ( b. 1 to 5 years ( e. 16 to 20 years ( c. 6 to 10 years
  14. www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/overview/background/measures-AS-1.pdf
    December 16, 2010 - Numerator: For 12-24 months, 25 months-6 years: One or more visits with a primary care physician during … For 7-11 years, 12-19 years: One or more visits with a primary care physician during the measurement … Denominator: Members who are 12 months through 24 months, 25 months through 6 years, 7 years through … 11 years, and 12 years through 19 years of age as of December 31 of the measurement year.
  15. www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-150-section-2-tech-specs.pdf
    November 01, 2014 - Specification – State Level Measure Description The percentage of children and adolescents 1 to 20 years … Eligible Population Ages 1 to 20 years by December 31 of the measurement year. …  1-5 years  6-11 years  12-17 years  18-20 years  Total. … Ages 1 year of age to 17 years as of December 31 of the measurement year. … Report three age stratifications and a total rate:  1–5 years.  6–11 years.  12–17 years.
  16. www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/toolkits/input-file-specifications.xlsx
    January 01, 2014 - medical claims source table Blank Blank Blank Note: Data for comorbidity claims cover a total of two years … had any comorbidities that involved the dermatological body system numeric (1/0) Calculated using 2 years … had any comorbidities that involved the genitourinary body system numeric (1/0) Calculated using 2 years … had any comorbidities that involved the hematological body system numeric (1/0) Calculated using 2 years … had any comorbidities that involved the immunological body system numeric (1/0) Calculated using 2 years
  17. www.cahps.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/2019-pharmacy-sops-database-report-appendix.pdf
    January 01, 2019 - 3 Years to <6 Years 6 Years to <12 Years 12 Years or More # Community Pharmacies 88 87 179 … 3 Years to <6 Years 6 Years to <12 Years 12 Years or More # Community Pharmacies 88 87 179 … <6 Months 6 Months to <1 Year 1 Year to <3 Years 3 Years to <6 Years 6 Years to <12 Years … <6 Months 6 Months to <1 Year 1 Year to <3 Years 3 Years to <6 Years 6 Years to <12 Years … <6 Months 6 Months to <1 Year 1 Year to <3 Years 3 Years to <6 Years 6 Years to <12 Years
  18. www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-145-materials-vii-a.pdf
    January 01, 2010 - code in the measurement year (2011) Follow- % of Denominator up Visit 2010-2011 4-5 years … 245,024 126,173 51% 10,620 8% 2,489 23.43% 1,780 16.76% 5,703 53.70% 7,249 68.25% 6-12 years 713,045 … 377,224 53% 66,825 18% 14,798 22.14% 8,776 13.13% 34,675 51.88% 44,888 67.16% 13-18 years 490,828 … 10,055 7% 2,306 22.93% 1,331 13.24% 3,159 31.41% 5,131 51.03% 4-18 years 902,756 498,472 55% 45,574 … 5% 664 16.96% 411 10.50% 1,707 43.61% 2,204 56.30% 13-18 years 93,703 32,379 35% 950 3% 147 15.47%
  19. www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-section-2-technical-specs.pdf
    April 30, 2018 - Children Administrative Specification Measure Description The percentage of children 0 to 20 years … Eligible Population Product Line Medicaid Ages 0 to 20 years by December 31 of the measurement year …  0-5 years  6-11 years  12-17 years  18-20 years  Total The total is the sum of the
  20. www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-145-materials-vi-a.pdf
    March 01, 2011 - DESCRIPTION Percentage of patients aged 4 through 18 years with a diagnosis of Attention Deficit Hyperactivity … 2,097 22.8% 18 0.2% 3 0.0% 4-18 years 3,114,809 100% 1,614,857 52% 58,528 3.62% 47,920 2.97% 9,186 … 649,522 13-18 years 1,064,132 533,850 481,935 415,127 359,310 326,717 4-18 years 3,105,806 1,755,481 … Commercial 2010-2011 4-5 years 1,767,905 922,570 874,406 802,688 745,524 717,715 6-12 years 6,635,306 … years 3,105,806 1,614,146 91,240 75,391 58,448 9,575 5,983 2,922 1,694 1b.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: